L-Ornithine, N5-[imino(α-D-ribofuranosylamino)methyl]-, (5′→P′)-ester with adenosine 5′-(trihydrogen diphosphate)
-
![L-Ornithine, N5-[imino(α-D-ribofuranosylamino)methyl]-, (5′→P′)-ester with adenosine 5′-(trihydrogen diphosphate) structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220812/ee122c1d95474130a778a2d30598f555.png "L-Ornithine, N5-[imino(α-D-ribofuranosylamino)methyl]-, (5′→P′)-ester with adenosine 5′-(trihydrogen diphosphate)")
L-Ornithine, N5-[imino(α-D-ribofuranosylamino)methyl]-, (5′→P′)-ester with adenosine 5′-(trihydrogen diphosphate)
structure -
-
CAS No:
103960-56-1
-
Formula:
C21H35N9O15P2
-
Chemical Name:
L-Ornithine, N5-[imino(α-D-ribofuranosylamino)methyl]-, (5′→P′)-ester with adenosine 5′-(trihydrogen diphosphate)
-
Synonyms:
L-Ornithine,N5-[imino(α-D-ribofuranosylamino)methyl]-,(5′→P′)-ester with adenosine 5′-(trihydrogen diphosphate);L-Ornithine,N5-[[[5-O-[hydroxy(phosphonooxy)phosphinyl]-α-D-ribofuranosyl]amino]iminomethyl]-,P′→5′-ester with adenosine;ADP-ribosylarginine;α-ADP-ribosylarginine
-
CAS No:
Description
N(omega)-(ADP-D-ribosyl)-L-arginine is a L-arginine derivative. It has a role as an EC 3.4.21.26 (prolyl oligopeptidase) inhibitor. It derives from an ADP-D-ribose. It is a conjugate acid of a N(omega)-(ADP-D-ribosyl)-L-arginine(1-).
L-Ornithine, N5-[imino(α-D-ribofuranosylamino)methyl]-, (5′→P′)-ester with adenosine 5′-(trihydrogen diphosphate) Basic Attributes
715.5 g/mol
715.50
D5024CP23U
Computed Properties
Molecular Weight:715.5
XLogP3:-9.5
Hydrogen Bond Donor Count:11
Hydrogen Bond Acceptor Count:21
Rotatable Bond Count:16
Exact Mass:715.17278544
Monoisotopic Mass:715.17278544
Topological Polar Surface Area:385
Heavy Atom Count:47
Complexity:1210
Defined Atom Stereocenter Count:9
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
Adenosine 5′-(trihydrogen diphosphate), P′→5′-ester with 1-(1,4-dihydro-1-β-D-ribofuranosyl-3-pyridinyl)ethanone, disodium salt
102029-93-6
-
Adenosine 5′-(trihydrogen diphosphate), P′-anhydride with phosphorothioic acid, lithium salt (1:4)
93839-89-5
-
Adenosine 5′-(trihydrogen diphosphate), P′→5′-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium, inner salt, lithium salt (1:1)
64417-72-7
-
Adenosine 5′-(trihydrogen diphosphate), 3′-(dihydrogen phosphate), P′→5′-ester with 3-(aminocarbonyl)-1-α-D-ribofuranosylpyridinium, inner salt, sodium salt Formula
108392-03-6
-
Sodium adenosine 5′-(trihydrogen diphosphate) 2′-(dihydrogen phosphate) P′→5′-ester with 1,4-dihydro-1-β-D-ribofuranosyl-3-pyridinecarboxamide (4:1) Formula
2646-71-1
-
Riboflavin 5′-(trihydrogen diphosphate), 6-hydroxy-, P′→5′ ester with adenosine Formula
52301-43-6
-
Adenosine 5′-(trihydrogen diphosphate), P′→5′-ester with 3-carboxy-1-β-D-ribofuranosylpyridinium inner salt, monosodium salt Structure
104809-30-5
-
Adenosine 5′-(trihydrogen diphosphate), P′→5′-ester with 3-(aminocarbonyl)-1-α-D-arabinofuranosylpyridinium inner salt Structure
108646-17-9
-
What is Adenosine 5′-(trihydrogen diphosphate), 2′-(dihydrogen phosphate), P′→5′-ester with 3-(aminocarbonyl)-1-β-D-ribofuranosylpyridinium, inner salt, disodium salt
24292-60-2
-
What is Adenosine 5′-(trihydrogen diphosphate), P′-anhydride with phosphorothioic acid
35094-46-3
Request for Quotation